Cstonepharma / 基石药业

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	基石药业
Description	基石药业为满足癌症患者需求而生，专注于开发及商业化创新肿瘤免疫治疗及分子靶向药物。成立2年多以来，公司已集结世界级的管理团队，在临床前研究、临床开发以及商业化方面拥有丰富经验。
Keywords	基石药业

Server Information

WebSite	www.cstonepharma.com
Host IP	203.107.43.165
Location	Hangzhou, Zhejiang, China

Related Websites

                    Site
                    Rank
                

More to Explore

cybirdpunk.tumblr.com

rongyuhuafu.tmall.com

safelive.events

Cstonepharma.com Valuation

US$11,040

Last updated: Jun 9, 2020

Cstonepharma.com has global traffic rank of 4,603,069. Cstonepharma.com has an estimated worth of US$ 11,040, based on its estimated Ads revenue. Cstonepharma.com receives approximately 672 unique visitors each day. Its web server is located in Hangzhou, Zhejiang, China, with IP address 203.107.43.165. According to SiteAdvisor, cstonepharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$11,040
Daily Ads Revenue	US$6
Monthly Ads Revenue	US$181
Yearly Ads Revenue	US$2,208
Daily Unique Visitors	672
Note: All traffic and earnings values are estimates.

Traffic Ranks

Global Rank	4,603,069
Delta (90 Days)	0
Most Popular In Country	N/A
Country Rank	N/A

DNS Records

Host	Type	TTL	Data
cstonepharma.com	A	599	IP: 203.107.43.165
cstonepharma.com	MX	599	Priority: 10 Target: haiwaigateway01.xfservice.com.
cstonepharma.com	MX	599	Priority: 10 Target: haiwaigateway.xfservice.com.
cstonepharma.com	NS	21599	Target: dns3.hichina.com.
cstonepharma.com	NS	21599	Target: dns4.hichina.com.
cstonepharma.com	TXT	599	TXT: MS=ms49956907
cstonepharma.com	SOA	599	MNAME: dns3.hichina.com. RNAME: hostmaster.hichina.com. Serial: 2016013120 Refresh: 3600 Retry: 1200 Expire: 3600 Minimum TTL: 360

HTTP Headers

HTTP/1.1 302 Found
Server: Tengine
Date: Tue, 09 Jun 2020 05:25:35 GMT
Content-Type: text/html;charset=utf-8
Content-Length: 0
Connection: close
BackendServer: Aliyun URL Forwarding Server
Location: http://www.cstonepharma.com

HTTP/1.1 200 OK
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Content-Type: text/html
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Server: Microsoft-IIS/7.5
X-Powered-By: PHP/5.3.29
Set-Cookie: ZDEDebuggerPresent=php,phtml,php3; path=/
Set-Cookie: PHPSESSID=h7pocl44bkpt4jp43uqr4l2la1; path=/
X-Powered-By: ASP.NET
Date: Tue, 09 Jun 2020 05:25:37 GMT
Content-Length: 21051

Cstonepharma.com Whois Information

   Domain Name: CSTONEPHARMA.COM
   Registry Domain ID: 1998964418_DOMAIN_COM-VRSN
   Registrar WHOIS Server: grs-whois.hichina.com
   Registrar URL: http://www.net.cn
   Updated Date: 2020-01-21T01:50:16Z
   Creation Date: 2016-01-31T12:59:11Z
   Registry Expiry Date: 2022-01-31T12:59:11Z
   Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd.
   Registrar IANA ID: 420
   Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com
   Registrar Abuse Contact Phone: +86.95187
   Domain Status: ok https://icann.org/epp#ok
   Name Server: DNS3.HICHINA.COM
   Name Server: DNS4.HICHINA.COM
   DNSSEC: unsigned
   URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/

Domain Name: cstonepharma.com
Registry Domain ID: 1998964418_DOMAIN_COM-VRSN
Registrar WHOIS Server: grs-whois.hichina.com
Registrar URL: http://whois.aliyun.com
Updated Date: 2020-01-21T01:50:16Z
Creation Date: 2016-01-31T12:59:11Z
Registrar Registration Expiration Date: 2022-01-31T12:59:11Z
Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd.
Registrar IANA ID: 420
Reseller:
Domain Status: ok https://icann.org/epp#ok
Registrant City: 
Registrant State/Province: shang hai
Registrant Country: CN
Registrant Email:https://whois.aliyun.com/whois/whoisForm
Registry Registrant ID: Not Available From Registry
Name Server: DNS3.HICHINA.COM
Name Server: DNS4.HICHINA.COM
DNSSEC: unsigned
Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com
Registrar Abuse Contact Phone: +86.95187
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/

Cstonepharma.com valuation and analysis